Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women

被引:12
作者
Gomora, Maria J. [1 ]
Morales-Vasquez, Flavia [2 ]
Pedernera, Enrique [1 ]
Perez-Montiel, Delia [3 ]
Lopez-Basave, Horatio [4 ]
Villas, Antonio R. [5 ]
Hernandez-Martinez, Azucena [6 ]
Mena, Esteban [7 ]
Mendez, Carmen [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Dept Embriol, Cdmx, Mexico
[2] Secretaria Salud Mexico, Inst Nacl Cancerol, Dept Oncol Mod, Cdmx, Mexico
[3] Secretaria Salud Mexico, Inst Nacl Cancerol, Dept Patol, Cdmx, Mexico
[4] Secretaria Salud Mexico, Inst Nacl Cancerol, Dept Cirugia Oncol, Cdmx, Mexico
[5] Univ Nacl Autonoma Mexico, Fac Med, Div Invest, Cdmx, Mexico
[6] Secretaria Def Nacl, Hosp Mil Especialidades Mujer & Neonatol, Cdmx, Mexico
[7] Univ Nacl Autonoma Mexico, Unidad Apoyo Acad, Fac Med, Secretaria Gen, Cdmx, Mexico
关键词
ovarian cancer; steroid hormones; hormone receptors; proliferation index; ovarian carcinoma; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; CANCER; EXPRESSION; SURVIVAL; PROGNOSIS; MARKER; TUMORS;
D O I
10.1530/EC-18-0158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The significance of the presence of androgen receptor (AR), estrogen receptor alpha (ER) and progesterone receptor (PR) in ovarian cancer patient survival has been a matter of numerous studies. This study was aimed to describe the expression profile of the three sexual steroid receptors in high-grade serous, endometrioid, mucinous and low-grade serous ovarian carcinoma and its association to the proliferation index in patients with primary ovarian carcinoma diagnosis, before any treatment. Eighty-one samples were obtained from the National Institute of Cancerology in Mexico City and were evaluated for the presence of AR, ER, PR and Ki67 by immunohistochemistry. The four subtypes of ovarian carcinoma displays a specific profile of the eight possible combinations of the steroid receptors with significant differences within the profile and the histological subtypes. High-grade serous carcinoma was characterized by a high frequency of both, triple-negative and AR+ ER- PR+ profiles. Endometrioid carcinoma presented a higher frequency of triple-positive profile. The presence of only AR+ profile was not observed in the endometrioid tumors. The relationship of the receptor profile with the proliferation index in the tumor epithelium shows that the expression of only ER is associated to a reduced proliferation index in endometrioid carcinoma. Steroid hormone receptor expression and co-expression could help characterize ovarian carcinoma.
引用
收藏
页码:1006 / 1012
页数:7
相关论文
共 34 条
[1]   Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors [J].
Arias-Pulido, Hugo ;
Smith, Harriet O. ;
Joste, Nancy E. ;
Bocklage, Therese ;
Qualls, Clifford R. ;
Chavez, Allison ;
Prossnitz, Eric R. ;
Verschraegen, Claire F. .
GYNECOLOGIC ONCOLOGY, 2009, 114 (03) :480-485
[2]  
ARMITAGE P, 2001, STATISTICAL METHODS
[3]   Androgen receptor in estrogen receptor positive breast cancer: Beyond expression [J].
Basile, Debora ;
Cinausero, Marika ;
Iacono, Donatella ;
Pelizzari, Giacomo ;
Bonotto, Marta ;
Vitale, Maria Grazia ;
Gerratana, Lorenzo ;
Puglisi, Fabio .
CANCER TREATMENT REVIEWS, 2017, 61 :15-22
[4]  
BERAL V, 1978, LANCET, V1, P1083
[5]   Steroid hormone synthesis by the ovarian stroma surrounding epithelial ovarian tumors: a potential mechanism in ovarian tumorigenesis [J].
Blanco, Luis Z., Jr. ;
Kuhn, Elisabetta ;
Morrison, Jane C. ;
Bahadirli-Talbott, Asli ;
Smith-Sehdev, Anne ;
Kurman, Robert J. .
MODERN PATHOLOGY, 2017, 30 (04) :563-576
[6]   Progesterone Inhibits Endometrial Cancer Invasiveness by Inhibiting the TGFβ Pathway [J].
Bokhari, Amber A. ;
Lee, Laura R. ;
Raboteau, Dewayne ;
Hamilton, Chad A. ;
Maxwell, George L. ;
Rodriguez, Gustavo C. ;
Syed, Viqar .
CANCER PREVENTION RESEARCH, 2014, 7 (10) :1045-1055
[7]   The role of sex hormones and steroid receptors on female reproductive cancers [J].
de Almeida Chuffa, Luiz Gustavo ;
Lupi-Junior, Luiz Antonio ;
Costa, Aline Balandis ;
Amorim, Joao Paulo de Arruda ;
Seiva, Fabio Rodrigues Ferreira .
STEROIDS, 2017, 118 :93-108
[8]  
Feng Z, 2016, SCI REP-UK, V6, P1, DOI DOI 10.1038/SREP25408)
[9]  
Ferlay J., GLOBOCAN
[10]  
Hogdall EVS, 2007, ONCOL REP, V18, P1051